Loading clinical trials...
Loading clinical trials...
Randomized, Open-Label, Comparative Study to Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Naive Adults With Chronic Hepatitis B Infection
The purpose of this study is to evaluate antiviral activity and efficacy of entecavir (ETV) compared to adefovir in adults with chronic hepatitis B who have not been treated yet with an antiviral medicine.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
Local Institution
San Diego, California, United States
Local Institution
San Francisco, California, United States
Local Institution
Torrance, California, United States
Local Institution
Miami, Florida, United States
Local Institution
North Miami Beach, Florida, United States
Local Institution
Baltimore, Maryland, United States
Local Insitution
New York, New York, United States
Local Institution
New York, New York, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Dallas, Texas, United States
Start Date
December 1, 2004
Primary Completion Date
January 1, 2006
Completion Date
April 1, 2008
Last Updated
August 10, 2010
69
ACTUAL participants
entecavir
DRUG
adefovir
DRUG
Lead Sponsor
Bristol-Myers Squibb
NCT07024641
NCT07422922
NCT06671093
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions